BioRestorative Therapies, Inc. (BRTX) stock
Close on Nov 16, 2026Market cap $36.18MP/E –Yield –
Earnings
BioRestorative Therapies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of BioRestorative Therapies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | Nov 12, 2025after the close | – | – | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 12, 2025after the close | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 14, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 27, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 13, 2024after the close | $230.70K | – | -$0.13 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 13, 2024after the close | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
BioRestorative Therapies has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When BioRestorative Therapies puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases BioRestorative Therapies filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Results
- Update
- Update
- Results
- Update
- Update
- Results
- Results
- Update
- Update
- Results
See a number that looks wrong?